
Aptiv is rated a buy with a price target of $68, implying an 82% upside, but the analyst does not own the stock due to concerns. Despite improving sales, Aptiv's earnings growth is weak, with 2027 revenue expected to be flat excluding recoveries and EBITDA margins possibly declining. The main issue is poor cash conversion, as free cash flow was negative $2 million over nine months while buybacks reached $558 million. The analyst prefers competitors like Autoliv, Magna, and Lear for their stronger cash generation and dividends, noting Aptiv needs a turnaround beyond just a low valuation to realize its potential.
Aptiv's market cap stands at $7.56 billion with a trading volume of 2,152,549 shares as of Nov 21, 2026, 15:11 WIB. On Pluang, the stock price is $35.33, down 5.43% for the day, reflecting active trading despite the analyst's concerns about cash flow and earnings growth. The typical hold time on Pluang is 51 days, indicating moderate investor interest in this consumer cyclical stock.